Importantly, all messages secured in this manuscript are complementary to the known information published in refs. [9,10] to confer a complete development for a new laboratory biomarker of MCP-1 and a new DAS28 evaluation formula of DAS28-MCP-1 in assessing the disease activity of patients with rheumatoid arthritis. The gene discussed is CCL2; the disease is rheumatoid arthritis.